Veru Inc.
General ticker "VERU" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $60.3M (TTM average)
Veru Inc. follows the US Stock Market performance with the rate: 3.2%.
Estimated limits based on current volatility of 2.7%: low 2.67$, high 2.81$
Factors to consider:
- Total employees count: 210 (+11.1%) as of 2024
- US accounted for 31.7% of revenue in the fiscal year ended 2024-09-30
- Top business risk factors: Operational and conduct risks, Dependence on external financing, Regulatory and compliance, Market competition, IP protection failure
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [1.99$, 6.42$]
- 2026-09-30 to 2027-09-30 estimated range: [1.97$, 6.23$]
Financial Metrics affecting the VERU estimates:
- Positive: with PPE of -2.2 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -57.22 <= 0.28
- Positive: Investing cash flow per share per price, % of 47.88 > -0.64
- Positive: 42.26 < Shareholder equity ratio, % of 61.45 <= 63.63
- Negative: negative Net income
- Positive: Inventory ratio change, % of -19.71 <= -0.75
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term VERU quotes
Long-term VERU plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $16.30MM | $16.89MM | $0.00MM |
| Operating Expenses | $110.08MM | $53.80MM | $24.75MM |
| Operating Income | $-93.78MM | $-36.92MM | $-24.75MM |
| Non-Operating Income | $1.11MM | $-0.16MM | $9.07MM |
| Interest Expense | $2.43MM | $0.61MM | $0.00MM |
| R&D Expense | $51.20MM | $12.81MM | $15.59MM |
| Income(Loss) | $-92.67MM | $-37.08MM | $-15.68MM |
| Taxes | $0.48MM | $0.73MM | $0.00MM |
| Net Income(Loss)* | $-93.15MM | $-37.80MM | $-22.73MM |
| Stockholders Equity | $19.68MM | $32.32MM | $18.33MM |
| Inventory | $6.70MM | $4.14MM | $0.00MM |
| Assets | $50.02MM | $60.42MM | $29.84MM |
| Operating Cash Flow | $-88.01MM | $-21.68MM | $-30.04MM |
| Capital expenditure | $0.67MM | $0.16MM | $0.00MM |
| Investing Cash Flow | $6.33MM | $0.15MM | $25.14MM |
| Financing Cash Flow | $11.11MM | $36.83MM | $-4.22MM |
| Earnings Per Share** | $-10.96 | $-2.80 | $-1.55 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.